Dr. Patel attended Rutgers – New Jersey Medical School and Rutgers - Graduate School of Biomedical Sciences from 2006-13, where he completed the physician-scientist training program (PSTP). He trained in the disciplines of stem cell biology and cancer biology. His thesis research focused on breast cancer dormancy in the bone marrow. He then completed Internal Medicine residency at Stanford University (2013-16) and Hematology/Oncology fellowship at Stanford University (2016-19), during which time he studied the leukemic stem cell niche in acute myeloid leukemia (AML). He is board-certified in Internal Medicine (2016), Hematology (2019), and Medical Oncology (2019).

He is Co-Director of the Blood, Immunity, and Infection course at UMass Chan Medical School.

His current research involves understanding the disease biology and clonal dynamics of TP53-mutant MDS and AML, as well as the genomics of clonal hematopoiesis (Patel SA et al., Br J Haematol 2024).

The Darkest Side of AML: The TP53 Mutation (umassmed.edu)

Oncology Times (lww.com)

Unpacking CHIP: Recent Updates, Remaining Questions | Blood Cancers Today

Dr Patel on the Impact of Donor-Engrafted Clonal Hematopoiesis on Outcomes With Auto-/Allo-HSCT (onclive.com)

Effects of donor-engrafted clonal hematopoiesis in stem cell transplantation - presented by Shyam Patel